Pearson T C
Department of Hematological Medicine, The Guy's, King's, and St Thomas' Hospitals' Medical School, Lambeth Palace Road, London SE1 7EH, UK.
Semin Hematol. 2001 Jan;38(1 Suppl 2):21-4. doi: 10.1016/s0037-1963(01)90136-2.
There is no single diagnostic marker for the only known type of primary acquired erythrocytosis, polycythemia vera (PV). The Polycythemia Vera Study Group (PVSG) used a combination of major and minor diagnostic criteria. However, these guidelines have some limitations and in the presence of newer diagnostic tools, have been re-evaluated. The recommendations of the Radionuclide Panel of the International Council for Standardization Hematology based on surface area are recommended over red blood cell mass (RCM) mL/kg expressions. Absolute erythrocytosis can be assumed in males and females with packed cell volume (PCV) values greater than 0.60 and greater than 0.56, respectively. A satisfactory strategy of investigation for a secondary erythrocytosis must be used. Hypoxemia, as well as renal and hepatic pathology, must be excluded. In unexplained absolute erythrocytoses, pO(2)(50) values and serum erythropoietin (EPO) levels should be examined. The latter can be disappointing in the confirmation of a secondary erythrocytosis, but elevated values contraindicate a diagnosis of a primary erythrocytosis. Establishment of a clonal marrow population supports a diagnosis of PV. Thus an acquired karyotypic abnormality is a major criterion. Palpable splenomegaly remains an important diagnostic marker. Scanning techniques to demonstrate splenic enlargement should be used with caution. Allowance must be made for interobserver and intraobserver differences and variation in normal spleen size with age and size of the subject. Splenomegaly demonstrated in this way should be taken as a minor criterion. An increased neutrophil count (>10 x 10(9)/L and >12.5 x 10(9)/L in smokers) is readily measurable and should replace total white blood cell count. The error in measurement of neutrophil alkaline phosphatase (NAP) score is large, making it an unsuitable diagnostic criterion. Neutrophil and platelet counts (>400 x 10(9)/L) should be taken as separate minor criteria. Endogenous erythroid colonies (EEC) grown from the peripheral blood have been used as a marker of PV, but it is an expensive technique that is not standardized and not totally specific for PV. Low serum EPO values found in the majority of patients with PV should hold a linked minor criterion position with EEC. Expert opinions should be obtained if bone marrow histology is to be used in the diagnosis of PV, but histology holds an important role in confirming the diagnosis. Semin Hematol 38(suppl 2):21-24.
对于唯一已知的原发性获得性红细胞增多症——真性红细胞增多症(PV),不存在单一的诊断标志物。真性红细胞增多症研究组(PVSG)采用了主要和次要诊断标准的组合。然而,这些指南存在一些局限性,并且在出现更新的诊断工具后,已被重新评估。基于表面积的国际血液学标准化理事会放射性核素小组的建议比红细胞容量(RCM)mL/kg表示法更受推荐。男性和女性的血细胞比容(PCV)值分别大于0.60和大于0.56时,可假定为绝对红细胞增多症。必须采用一种令人满意的继发性红细胞增多症的检查策略。必须排除低氧血症以及肾脏和肝脏病变。在不明原因的绝对红细胞增多症中,应检查pO(2)(50)值和血清促红细胞生成素(EPO)水平。后者在确认继发性红细胞增多症时可能令人失望,但升高的值排除了原发性红细胞增多症的诊断。克隆性骨髓群体的建立支持PV的诊断。因此,获得性核型异常是主要标准。可触及的脾肿大仍然是一个重要的诊断标志物。用于显示脾肿大的扫描技术应谨慎使用。必须考虑观察者间和观察者内的差异以及正常脾脏大小随年龄和受试者体型的变化。以这种方式显示的脾肿大应作为次要标准。中性粒细胞计数增加(吸烟者>10×10(9)/L,非吸烟者>12.5×10(9)/L)易于测量,应取代白细胞总数。中性粒细胞碱性磷酸酶(NAP)评分的测量误差很大,使其成为不合适的诊断标准。中性粒细胞和血小板计数(>400×10(9)/L)应作为单独的次要标准。从外周血中生长的内源性红系集落(EEC)已被用作PV的标志物,但这是一种昂贵的技术,未标准化且并非完全特异性地针对PV。大多数PV患者中发现的低血清EPO值应与EEC一起作为相关的次要标准。如果要将骨髓组织学用于PV的诊断,应征求专家意见,但组织学在确认诊断中起着重要作用。《血液学 Seminars》38(增刊2):21 - 24。